SPONSOR
bioLytical Laboratories
Total Trials
2
Recruiting
2
Phases
N/A
Conditions studied: HIV 1 InfectionHIV 2 InfectionSyphilis InfectionHepatitis B InfectionGonorrhea Infection
bioLytical Laboratories is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including HIV 1 Infection, HIV 2 Infection, Syphilis Infection, Hepatitis B Infection.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — bioLytical Laboratories
How many clinical trials has bioLytical Laboratories sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by bioLytical Laboratories, of which 2 are actively recruiting participants. These trials cover conditions including HIV 1 Infection, HIV 2 Infection, Syphilis Infection. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does bioLytical Laboratories research focus on?
bioLytical Laboratories clinical trials span HIV 1 Infection, HIV 2 Infection, Syphilis Infection, Hepatitis B Infection, Gonorrhea Infection. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a bioLytical Laboratories clinical trial?
To participate in a bioLytical Laboratories trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all bioLytical Laboratories trials with current recruitment status updated daily.
Clinical Trials by bioLytical Laboratories
NCT07563309
Recruiting
A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test
HIV 1 Infection
NCT07569900
Recruiting
A Study to Evaluate the Performance, Usability, and Contrived Result Interpretation of iStatis Gonorrhea Antigen Test
Gonorrhea Infection
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology